Polaryx Therapeutics

PLYX · NASDAQ

$1.91−$0.01 (−0.52%)TodayMarket closed ·
Prev close $1.92

PLYX analyst rating

BuyConsensus of 4 analysts over the last 12 months. 100% rate it a buy.
  • Strong buy1
  • Buy3
  • Hold0
  • Underperform0
  • Sell0

12-month price target · 6 analysts

Average $7.65 (+300.5% upside)

Low
$6.06
Now
$1.91
High
$10.50

Upgrades and downgrades

The latest rating actions, newest first

PLYX analyst upgrades, downgrades and rating actions
FirmDateActionRating
Raymond JamesAug 13, 2026InitiatesStrong Buy
LUCID CAPITAL MARKETSJul 27, 2026InitiatesBuy
HC Wainwright & Co.Jul 9, 2026InitiatesBuy
Maxim GroupFeb 27, 2026InitiatesBuy

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.